Fatty acid type–specific regulation of SIRT1 does not affect insulin sensitivity in human skeletal muscle
Open Access
- 1 February 2019
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 33 (4) , 5510-5519
Abstract
The nicotinamide adenine dinucleotide–dependent deacetylase, sirtuin (SIRT)1, in skeletal muscle is reduced in insulin‐resistant states. However, whether this is an initial mechanism responsible for mediating insulin resistance in human skeletal muscle remains to be investigated. Also, SIRT1 acts as a mitochondrial gene transcriptional regulator and is induced by a short‐term, high‐fat diet (HFD) in human skeletal muscle. Whether saturated or unsaturated fatty acids (FAs) in the diet are important for this is unknown. We subjected 17 healthy, young men to a eucaloric control (Con) diet and 1 of 2 hypercaloric [+75% energy (E%)] HFDs for 3 d enriched in either saturated (Sat) FA (79 E% fat; Sat) or unsaturated FA (78 E% fat; Unsat). After Sat, SIRT1 protein content and activity in skeletal muscle increased ( P < 0.05; ∼40%) while remaining unchanged after Unsat. Whole‐body insulin sensitivity and insulin‐stimulated leg glucose uptake were reduced ( P < 0.01; ∼20%) to a similar extent compared to Con after both HFDs. We demonstrate a novel FA type‐dependent regulation of SIRT1 protein in human skeletal muscle. Moreover, regulation of SIRT1 does not seem to be an initiating factor responsible for mediating insulin resistance in human skeletal muscle.—Fritzen, A. M., Lundsgaard, A.‐M., Jeppesen, J. F., Sjøberg, K. A., Høeg, L. D., Deleuran, H. H., Wojtaszewski, J. F. P., Richter, E. A., Kiens, B. Fatty acid type–specific regulation of SIRT1 does not affect insulin sensitivity in human skeletal muscle. FASEB J. 33, 5510–5519 (2019). www.fasebj.orgKeywords
Funding Information
- Ministeriet for Fø devarer, Landbrug og Fiskeri
- Sundhed og Sygdom, Det Frie Forskningsråd
- Lundbeck Foundation
- Novo Nordisk Fonden (NNF17SA0031406)
- European Commission (LSHM‐CT‐2004‐005272)
- Danish Agency for Higher Education and Science
- Alfred Benzon Foundation
This publication has 49 references indexed in Scilit:
- SIRT3 Deficiency and Mitochondrial Protein Hyperacetylation Accelerate the Development of the Metabolic SyndromeMolecular Cell, 2011
- Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in MiceCell Metabolism, 2011
- PARP-2 Regulates SIRT1 Expression and Whole-Body Energy ExpenditureCell Metabolism, 2011
- PARP-1 Inhibition Increases Mitochondrial Metabolism through SIRT1 ActivationCell Metabolism, 2011
- Hepatic-Specific Disruption of SIRT6 in Mice Results in Fatty Liver Formation Due to Enhanced Glycolysis and Triglyceride SynthesisCell Metabolism, 2010
- AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activityNature, 2009
- SirT1 Gain of Function Increases Energy Efficiency and Prevents Diabetes in MiceCell Metabolism, 2008
- Sirt1 protects against high-fat diet-induced metabolic damageProceedings of the National Academy of Sciences, 2008
- Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetesNature, 2007
- Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC‐1αThe EMBO Journal, 2007